Header Logo

Connection

LINGEGOWDA SELANERE MANGALA to Histone Deacetylase Inhibitors

Back to Details
This is a "connection" page, showing publications LINGEGOWDA SELANERE MANGALA has written about Histone Deacetylase Inhibitors.
LINGEGOWDA SELANERE MANGALA
Connection Strength
0.268
Histone Deacetylase Inhibitors
  1. EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer. Int J Mol Sci. 2024 Jan 20; 25(2).
    View in: PubMed
    Score: 0.169
  2. ?Np63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer. Cancer Cell. 2016 06 13; 29(6):874-888.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.